Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

The US Food and Drug Administration has granted approval to Greenwich Biosciences, the US subsidiary of GW Pharmaceuticals, for Epidiolex, for an oral solution of purified cannabidiol

Epidiolex, an oral solution of purified cannabidiol, has approved by the FDA for treating seizures caused by Lennox-Gastaut and Dravet syndromes, which are forms of epilepsy.

Source  PA / PA Archive / PA Images